BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16205109)

  • 21. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
    Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
    Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
    Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
    FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.
    Folini M; Colella G; Villa R; Lualdi S; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2000 Feb; 114(2):259-67. PubMed ID: 10651984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
    Qi Z; Mi R
    Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement.
    Won YS; Jeong JS; Kim SJ; Ju MH; Lee SW
    Cancer Lett; 2015 Jan; 356(2 Pt B):918-28. PubMed ID: 25444904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
    Vahidi S; Norollahi SE; Agah S; Samadani AA
    J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
    Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
    Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
    de Souza Nascimento P; Alves G; Fiedler W
    Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
    Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
    Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
    Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
    Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.
    Shen Y; Zhang YW; Zhang ZX; Miao ZH; Ding J
    Cancer Biol Ther; 2008 Feb; 7(2):228-36. PubMed ID: 18059183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
    Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
    Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
    Yi X; White DM; Aisner DL; Baur JA; Wright WE; Shay JW
    Neoplasia; 2000; 2(5):433-40. PubMed ID: 11191110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibition of anti-sense human telomerase reverse transcriptase (hTERT) retroviral vector on lung cancer cells].
    Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
    Ai Zheng; 2004 May; 23(5):545-9. PubMed ID: 15142451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects.
    Liu T; Liang X; Li B; Björkholm M; Jia J; Xu D
    Br J Cancer; 2013 Jun; 108(11):2272-80. PubMed ID: 23681187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer.
    Choi BJ; Yoon JH; Kim O; Choi WS; Nam SW; Lee JY; Park WS
    World J Gastroenterol; 2015 Aug; 21(31):9328-36. PubMed ID: 26309358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
    Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
    Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.